A Multicenter Study of IBI343 Monotherapy Versus Placebo in Subjects With Previously Treated, Claudin (CLDN) 18.2-positive, Pancreatic Cancer(G-HOPE-002)
Clinical trial NCT07066098 · RECRUITING
Trial details
- NCT number
- NCT07066098
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-04
- Primary completion
- 2027-06-30
- Enrollment
- 201
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.